Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Seoulin Bioscience Co Ltd banner
S

Seoulin Bioscience Co Ltd
KOSDAQ:038070

Watchlist Manager
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Watchlist
Price: 6 310 KRW -2.02%
Market Cap: ₩57.4B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-85%
5Y
-57%
10Y
-89%
Investing Cash Flow
+
3Y
+63%
5Y
-1 249%
10Y
-133%
Financing Cash Flow
+
3Y
-57%
5Y
-
10Y
+635%

Cash Flow Statement
Seoulin Bioscience Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
4 160
3 885
3 252
2 254
2 682
2 021
2 177
1 886
1 761
1 753
3 292
3 653
4 158
4 775
3 079
3 155
2 269
1 826
1 941
2 542
2 884
2 961
8 676
8 728
8 888
9 321
3 765
4 045
4 801
5 209
6 066
17 964
15 768
16 576
20 946
8 816
9 977
9 460
3 390
2 782
(2 323)
(3 444)
(2 897)
(3 097)
3 140
2 878
2 151
2 667
Depreciation & Amortization
646
690
740
789
808
807
814
832
824
821
806
782
779
755
737
843
1 074
1 294
1 536
1 662
1 658
1 676
1 681
1 670
1 653
1 640
1 691
1 822
1 984
2 000
2 034
2 006
1 930
1 758
1 498
1 253
1 017
1 056
1 109
1 264
1 287
1 340
1 378
1 295
1 365
1 339
1 281
1 219
Other Non-Cash Items
(1 234)
(1 634)
98
771
1 015
852
895
750
835
824
(879)
(777)
(582)
(461)
1 335
1 204
1 030
950
844
1 093
931
893
(5 500)
(6 044)
(5 831)
(5 831)
271
896
1 056
1 507
2 343
(8 957)
(7 437)
(7 113)
(9 998)
995
(1 291)
(1 370)
1 641
2 187
8 168
8 349
7 453
6 955
(982)
(2 121)
(1 994)
(1 774)
Cash Taxes Paid
1 679
1 775
448
451
609
543
434
386
198
305
441
483
533
751
1 035
1 158
1 262
876
398
263
142
0
485
510
536
1 551
2 488
2 561
2 634
1 842
853
847
668
2 530
4 591
5 030
5 837
4 106
2 248
2 097
1 408
1 115
1 266
1 113
1 295
1 057
480
264
Cash Interest Paid
209
195
202
173
157
143
139
129
118
106
61
25
71
78
115
156
121
114
102
83
62
48
35
22
16
15
16
20
19
20
16
14
14
14
12
11
11
12
22
37
21
22
30
24
48
57
44
41
Change in Working Capital
1 367
(802)
(2 371)
(1 363)
(1 765)
276
2 519
2 873
696
783
(3 502)
(4 712)
(1 600)
(6 769)
(293)
(1 322)
(3 072)
(836)
(3 985)
(855)
(1 299)
(754)
372
1 355
2 612
923
(716)
(5 094)
(4 156)
(1 480)
(818)
(2 623)
(1 343)
(9 839)
(11 366)
(6 268)
(14 059)
(5 859)
(12 228)
(12 363)
(6 201)
(6 779)
(1 250)
(3 704)
(8 135)
(4 030)
(4 037)
(1 391)
Cash from Operating Activities
4 939
N/A
2 139
-57%
1 718
-20%
2 450
+43%
2 739
+12%
3 955
+44%
6 405
+62%
6 341
-1%
4 117
-35%
4 182
+2%
(283)
N/A
(1 055)
-273%
2 755
N/A
(1 700)
N/A
4 858
N/A
3 879
-20%
1 301
-66%
3 234
+149%
335
-90%
4 442
+1 226%
4 174
-6%
4 776
+14%
5 230
+9%
5 709
+9%
7 321
+28%
6 052
-17%
5 011
-17%
1 669
-67%
3 685
+121%
7 237
+96%
9 624
+33%
8 390
-13%
8 918
+6%
1 382
-85%
1 080
-22%
4 796
+344%
(4 356)
N/A
3 287
N/A
(6 088)
N/A
(6 130)
-1%
931
N/A
(534)
N/A
4 684
N/A
1 450
-69%
(4 611)
N/A
(1 935)
+58%
(2 599)
-34%
722
N/A
Investing Cash Flow
Capital Expenditures
(90)
(128)
(265)
(790)
(1 128)
(4 019)
(4 026)
(3 755)
(3 743)
(2 851)
(4 315)
(6 241)
(7 214)
(10 267)
(11 669)
(10 722)
(9 544)
(4 678)
(2 214)
(940)
(952)
(827)
(461)
(590)
(708)
(844)
(753)
(1 010)
(943)
(1 145)
(1 702)
(1 531)
(1 670)
(1 932)
(719)
(870)
(707)
(467)
(1 101)
(1 143)
(974)
(539)
(419)
(319)
(62)
(20)
(109)
(249)
Other Items
(5 593)
(6 148)
(4 316)
375
(459)
(940)
(3 222)
(1 562)
(479)
6 110
11 629
12 137
11 010
7 525
2 948
920
4 524
2 847
3 896
3 333
1 317
522
194
(324)
(2 206)
(2 223)
(4 120)
92
1 652
963
1 693
1 251
(29 829)
(26 808)
(28 516)
(32 559)
(1 958)
(3 652)
4 373
8 800
28 500
31 712
27 224
24 553
6 452
2 161
(11 430)
(12 135)
Cash from Investing Activities
(5 682)
N/A
(6 276)
-10%
(4 581)
+27%
(415)
+91%
(1 587)
-282%
(4 960)
-213%
(7 247)
-46%
(5 318)
+27%
(4 222)
+21%
3 259
N/A
7 314
+124%
5 896
-19%
3 797
-36%
(2 742)
N/A
(8 721)
-218%
(9 802)
-12%
(5 020)
+49%
(1 830)
+64%
1 682
N/A
2 394
+42%
365
-85%
(305)
N/A
(268)
+12%
(914)
-242%
(2 914)
-219%
(3 067)
-5%
(4 872)
-59%
(918)
+81%
709
N/A
(182)
N/A
(9)
+95%
(280)
-2 947%
(31 499)
-11 148%
(28 739)
+9%
(29 235)
-2%
(33 428)
-14%
(2 665)
+92%
(4 119)
-55%
3 272
N/A
7 657
+134%
27 526
+260%
31 173
+13%
26 805
-14%
24 235
-10%
6 389
-74%
2 141
-66%
(11 539)
N/A
(12 384)
-7%
Financing Cash Flow
Net Issuance of Common Stock
1
0
(7)
(7)
(7)
0
985
1 870
1 567
1 048
471
(414)
(46)
0
36
36
71
71
65
195
95
0
(305)
(2 263)
(2 680)
(2 828)
(2 415)
(586)
(169)
0
(81)
(81)
(81)
0
(199)
(199)
2 151
0
2 207
2 207
(143)
0
(97)
(1 031)
(1 092)
0
(1 054)
(121)
Net Issuance of Debt
3 249
3 229
2 788
(1 790)
(1 800)
741
582
450
316
(6 920)
(6 675)
(5 012)
(4 589)
3 514
3 715
3 017
1 577
(2 384)
(3 237)
(4 640)
(4 055)
(3 787)
(3 627)
(2 593)
(1 490)
(231)
1 453
617
488
(15)
(914)
(148)
29 857
29 768
29 755
29 761
802
(245)
258
259
(21 573)
(26 309)
(28 448)
(29 350)
(5 525)
(3 821)
12 748
13 689
Cash Paid for Dividends
(598)
0
(650)
(650)
(650)
0
(676)
(676)
(676)
0
(737)
(737)
(737)
0
(776)
(776)
(776)
(776)
(644)
(644)
(644)
0
0
(1 030)
(1 030)
0
(1 751)
(721)
(721)
0
(769)
(769)
(769)
0
(798)
(798)
(798)
0
(1 062)
(1 062)
(1 062)
0
(836)
(836)
(836)
0
(844)
(844)
Other
0
0
0
0
19
0
0
0
0
0
0
0
(65)
0
1 435
1 435
1 500
1 500
400
400
400
0
0
1 500
1 500
0
0
0
0
0
0
0
0
0
0
0
(1 077)
0
0
0
0
0
0
0
0
0
(500)
(500)
Cash from Financing Activities
2 651
N/A
2 627
-1%
2 127
-19%
(2 447)
N/A
(2 438)
+0%
102
N/A
910
+789%
1 663
+83%
1 207
-27%
(6 549)
N/A
(6 940)
-6%
(6 163)
+11%
(5 437)
+12%
3 185
N/A
4 410
+38%
3 712
-16%
2 372
-36%
(1 589)
N/A
(3 416)
-115%
(4 689)
-37%
(4 204)
+10%
(3 936)
+6%
(3 931)
+0%
(4 387)
-12%
(3 700)
+16%
(2 589)
+30%
(1 212)
+53%
(690)
+43%
(402)
+42%
(757)
-88%
(1 764)
-133%
(998)
+43%
29 008
N/A
28 918
0%
28 758
-1%
28 763
+0%
1 077
-96%
1 108
+3%
1 403
+27%
1 403
+0%
(22 778)
N/A
(27 514)
-21%
(29 382)
-7%
(31 217)
-6%
(7 453)
+76%
(5 749)
+23%
10 350
N/A
12 224
+18%
Change in Cash
Effect of Foreign Exchange Rates
2
2
(1)
(0)
(2)
(2)
3
2
(1)
(1)
(2)
(2)
6
6
27
27
(40)
(40)
(63)
(63)
51
0
46
51
30
0
36
30
(36)
0
(12)
0
48
0
75
48
(30)
0
(0)
0
(76)
(19)
46
(76)
23
23
(155)
23
Net Change in Cash
1 910
N/A
(1 509)
N/A
(736)
+51%
(412)
+44%
(1 287)
-212%
(904)
+30%
70
N/A
2 688
+3 735%
1 101
-59%
891
-19%
89
-90%
(1 323)
N/A
1 121
N/A
(1 250)
N/A
573
N/A
(2 184)
N/A
(1 386)
+37%
(226)
+84%
(1 461)
-547%
2 084
N/A
386
-81%
535
+39%
1 076
+101%
460
-57%
738
+60%
397
-46%
(1 038)
N/A
91
N/A
3 955
+4 232%
6 297
+59%
7 839
+24%
7 112
-9%
6 475
-9%
1 561
-76%
678
-57%
178
-74%
(5 974)
N/A
276
N/A
(1 414)
N/A
2 930
N/A
5 603
+91%
3 106
-45%
2 154
-31%
(5 608)
N/A
(5 653)
-1%
(5 520)
+2%
(3 943)
+29%
586
N/A
Free Cash Flow
Free Cash Flow
4 850
N/A
2 010
-59%
1 453
-28%
1 660
+14%
1 611
-3%
(64)
N/A
2 379
N/A
2 586
+9%
374
-86%
1 331
+256%
(4 598)
N/A
(7 295)
-59%
(4 459)
+39%
(11 967)
-168%
(6 812)
+43%
(6 843)
0%
(8 243)
-20%
(1 444)
+82%
(1 879)
-30%
3 503
N/A
3 222
-8%
3 950
+23%
4 768
+21%
5 119
+7%
6 613
+29%
5 209
-21%
4 258
-18%
659
-85%
2 742
+316%
6 092
+122%
7 922
+30%
6 859
-13%
7 248
+6%
(550)
N/A
361
N/A
3 926
+986%
(5 063)
N/A
2 820
N/A
(7 189)
N/A
(7 273)
-1%
(44)
+99%
(1 072)
-2 357%
4 265
N/A
1 131
-73%
(4 674)
N/A
(1 955)
+58%
(2 709)
-39%
474
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.